Patients with moderate to severe Psoriasis, A skin disorder that causes skin cells to multiply up to 10 times faster than normal. This makes the skin build up into bumpy red patches covered with white scales, will be enrolled to evaluate new treatments for this skin condition. Clinical trial participants will be monitored closely by medical professionals for the duration of the study. The goal of this Psoriasis clinical trial is to develop better understanding of Psoriasis and develop safe and effective therapies.
Up to 136 weeks depending on study
Subject compensation and travel assistance may be available. Study medication, study related exams, and lab tests will be provided at no cost
For general questions regarding our clinical trials, please contact our team at firstname.lastname@example.org or fill out the contact form below.
A clinical trial is a research study conducted with human volunteers to test the effectiveness and safety of new drugs, devices, or interventions. Our Clearlyderm clinical trials focus on skin conditions such as psoriasis, acne, rosacea, or atopic dermatitis (eczema).
To enroll in one of our clinical trials, contact our office. You will need to review and complete informed consent documents and complete screening procedures prior to participation.
Like any medical treatment, potential risks exist. However, participants are informed of these risks prior to starting the clinical trials and receive monitoring and follow-up care throughout the trial duration if selected to participate.
Psoriasis is an autoimmune disorder that can affect people of any age. The most common type is called chronic plaque psoriasis. Symptoms include red patches of skin that can itch, burn, or feel sore.